检索

期
标题
作者
卷 30, 编号 8 (2023)
Rare clinical variant of palmoplantar keratoderma
Novikov Y., Pravdina O., Zykova E., Gamza S.
PDF
(Rus)
编号 3 (2018)
RATIONAL MUSCOLYTIC THERAPY IN THE THERAPEUTIC PRACTICE
Babak S., Gorbunova M., Malyavi A.
PDF
(Rus)
编号 1 (2011)
DIFFERENTIAL DIAGNOSIS AND GENERAL PRINCIPLES OF THERAPY OF CHRONIC DIARRHEA IN CHILDREN
Bel'mer S., Gasilina T., Belmer S., Gasilina T.
编号 18-19 (2010)
EFFECT OF MUTATIONS IN THE CFTR GENE ON COURSE OF CYSTIC FIBROSIS IN CHILDREN
Sergienko D., Bashkina O., M Galimzianov -., Sergienko D., Bashkina O., Galimzyanov K.
卷 29, 编号 10 (2022)
Targeted therapy in patients with cystic fibrosis in the Astrakhan region: first experience
Sergienko D., Bashkina O., Kuznetsova T.
PDF
(Rus)
编号 4 (2017)
Mycogenic sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis patients: results of prospective study
Kozlova Y., Sobolev A., Borzova Y., Suslova I., Aak O., Ignatyeva S., Bogomolova T., Stepanenko T., Orlov A., Klimko N.
PDF
(Rus)
编号 14 (2010)
CHANGE OF CONGENITAL IMMUNITY FACTORS IN CHILDREN WITH CYSTIC FIBROSIS
Sergienko D., Bashkina O., Galimzianov M., Sergienko D., Bashkina O., Galimzyanov K.
卷 29, 编号 5 (2022)
Cystic fibrosis register in the Astrakhan region: state of the problem according to 2021 data
Sergienko D., Bashkina O.
PDF
(Rus)
编号 3 (2014)
SOVREMENNYE FARMAKOTERAPEVTIChESKIE PODKhODY K LEChENIYu MUKOVISTsIDOZA
Kashirskaya N., Kapranov N.
PDF
(Rus)
编号 14 (2010)
RECURRENT POLYSINUSITIS AS LEADING CLINICAL SIGN OF CYSTIC FIBROSIS: SUCCESSFUL ENDONASAL USE OF DORNASE ALFA
Asherova I., Tarakanova V., Asherova I., Tarakanova V.
卷 27, 编号 10 (2020)
Features of the course of chronic lung diseases in children at the present stage
Vyazovaya I., Ikhsanov S., Averina I.
PDF
(Rus)
编号 2s (2013)
OSTEOPOROZ V PRAKTIKE PUL'MONOLOGA
Baranova I.
PDF
(Rus)
编号 5 (2010)
Clinical significance of ETN-organs injury in children with cystic fibrosis and their treatment on current stage
Kapranov N., Martynova I., Mosina V., Kashirskaya N., Kapranov N., Martynova I., Mosina V., Kashirskaya N.
卷 27, 编号 1 (2020)
Rationale for adequate enzyme replacement therapy for children with cystic fibrosis: a cross-sectional study
Maksimycheva T., Kondratyeva E., Sorvacheva T., Evdokimova T.
PDF
(Rus)
编号 5 (2012)
CURRENT APPROACHES TO THE THERAPY OF CYSTIC FIBROSIS
Kapranov N., Asherova I., Kapranov N., Asherova I.
编号 6 (2009)
Clinical significance of dornase alfa (Pulmozyme) in complex therapy of early age children suffering cystic fybrosis
Shelepneva N., Kashirskaya N., Sherman V., Kapranov N., Shelepneva N., Kashirskaya N., Sherman V., Kapranov N.
编号 5S (2018)
CYSTIC FIBROSIS: EVENTS AND NEWS
Simonova O., Gorinova Y., Ignatova A., Shestopalove E., Mukhina M., Popova O.
PDF
(Rus)
编号 3s (2012)
TERAPIYa EKZOKRINNOY NEDOSTATOChNOSTI PODZhELUDOChNOY ZhELEZY U DETEY, BOL'NYKh MUKOVISTsIDOZOM, NA PRIMERE PRIMENENIYa PREPARATA KREON
Kashirskaya N., Kapranov N.
PDF
(Rus)
编号 1 (2009)
Epidemiology and genetics of cystic fibrosis in Udmurt Republic
Simanova T., Ozhegov A., Simanova T., Ozhegov A.
编号 3 (2018)
FEATURES OF ASSOCIATED TRAITS OF 3272-16T>A MUTATION IN CYSTIC FIBROSIS IN CHILDREN: DESCRIPTION OF THREE CASES
Shadrina V., Krasovsky S., Furman E.
PDF
(Rus)
编号 11 (2011)
DORNASE ALPHA (PULMOZYME) FOR THE COMPLEX TREATMENT OF BRONCHOPULMONARY PROCESS IN CYSTIC FIBROSIS PATIENTS.
Sherman V., Kapranov N., Kashirskaya N., Sherman V., Kapranov N., Kashirskaya N.
1 - 21 的 21 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##